- Home
- OCS vs RXRX Comparison
OCS vs RXRX Comparison
Compare OCS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | RXRX |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OCS | RXRX |
|---|---|---|
| Price | $12.71 | $3.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $42.00 | $7.50 |
| AVG Volume (30 Days) | 280.4K | ★ 17.6M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $466.06 | $12.11 |
| Revenue Next Year | $479.73 | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $10.52 | $2.77 |
| 52 Week High | $34.48 | $7.18 |
Technical Indicators
Market Signals| Indicator | OCS | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 52.57 |
| Support Level | $10.63 | $2.87 |
| Resistance Level | $14.35 | $4.03 |
| Average True Range (ATR) | 0.59 | 0.15 |
| MACD | 0.32 | 0.03 |
| Stochastic Oscillator | 79.22 | 81.00 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.